← Open Payments lookup

RAHIMA AFGHAN: Open Payments

NPI 1023060449 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,205 in 50 payments from 14 companies in 2025. Trend: 2023 $1,588 · 2024 $1,383 · 2025 $1,205

Food & beverage: $1,205
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$249
ABBVIE INC.11$234
Otsuka America Pharmaceutical, Inc.7$143
E.R. Squibb & Sons, L.L.C.5$128
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$123
Lundbeck LLC4$109
Takeda Pharmaceuticals U.S.A., Inc.3$61
Teva Pharmaceuticals USA, Inc.2$45
Luye Pharma (USA) Ltd.1$23
Biogen, Inc.1$22

Products named: INGREZZA, VRAYLAR, REXULTI, COBENFY, CAPLYTA, TRINTELLIX, ABILIFY MAINTENA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.